comparemela.com

Latest Breaking News On - Concord biotech - Page 7 : comparemela.com

Rekha Jhunjhunwala purchases neighbouring building for Rs 118 cr for clear sea view from home: Report

S&P BSE Rejig: Honasa Consumer added to BSE FMCG Index, Tata Tech to BSE IT Index

Pharma Export data (Q4 QTD): Weak for Divi s/ Gland; strong for Sun/Zydus led by RevlimidIndia Infoline

Export data trends are strong for Suven+Cohance, Neuland, Granules, Poly Medicure and JB Pharma with Q4 QTD export shipments for these companies increasing QoQ by 14-48%.

3 stocks closed crossing above VWAP on March 7

A shift above the VWAP suggests a potential bullish trend, according to stockedge.com s technical scan data.

Ahead of Market: 10 things that will decide D-Street action on Monday

"22,250-22,200 is likely to be seen as intermediate support, followed by the strong support of 22,150 and finally, the psychological mark of 22,000 from a broader term view. On the higher end, finding resilience is challenging in uncharted territory, though 22,600-22,650 could be seen as the following potent targets for Nifty in the upcoming week," said Osho Krishan, Angel One.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.